| Consolidated income statement |
| Net sales, EUR million |
52.8 |
47.0 |
41.90 |
55.08 |
60.07 |
| change % |
12.4 |
12.2 |
-23.93 |
-8.32 |
-21.43 |
| Adjusted operating result, EUR million ¹ |
19.3 |
13.0 |
5.86 |
9.78 |
1.24 |
| % of net sales |
36.5 |
27.6 |
14.00 |
17.75 |
2.06 |
| Operating profit, EUR million |
18.6 |
14.4 |
5.27 |
-7.98 |
-10.09 |
| % of net sales |
35.3 |
30.6 |
12.59 |
-14.48 |
-16.79 |
| Profit before taxes, EUR million |
15.9 |
11.8 |
4.43 |
-10.51 |
-5.62 |
| % of net sales |
30.1 |
25.0 |
10.57 |
-19.09 |
-9.36 |
| Adjusted result for the period ² |
14.2 |
6.3 |
0.08 |
2.26 |
-4.23 |
| % of net sales |
27.0 |
13.4 |
0.18 |
4.10 |
-7.04 |
| Profit for the period, EUR million |
13.6 |
7.7 |
-0.51 |
-15.49 |
-6.29 |
| % of net sales |
25.7 |
16.4 |
-1.23 |
-28.13 |
-10.47 |
| |
|
|
|
|
|
| Consolidated balance sheet |
| Non-current assets, EUR million |
7.3 |
6.8 |
2.98 |
3.58 |
22.40 |
| Current assets |
|
|
|
|
|
| Inventories, EUR million |
0.0 |
0.0 |
0.13 |
0.46 |
0.90 |
| Trade and other receivables, EUR million |
35.3 |
26.7 |
21.29 |
25.51 |
33.00 |
| Investments and cash equivalents, EUR million |
8.0 |
3.4 |
4.16 |
2.29 |
3.50 |
| Shareholders' equity, EUR million |
19.9 |
3.6 |
-6.50 |
-6.09 |
10.70 |
| Liabilities |
|
|
|
|
|
| Non-current liabilities, EUR million |
18.8 |
21.8 |
18.30 |
24.22 |
32.80 |
| Current liabilities, EUR million |
12.0 |
11.5 |
16.70 |
13.72 |
16.30 |
| Balance sheet total, EUR million |
50.6 |
36.8 |
28.55 |
31.85 |
59.80 |
| |
|
|
|
|
|
| Financial indicators |
| Return on equity (ROE), % |
96.8 |
|
|
|
-43.9 |
| Return on investment (ROI), % |
87.3 |
105.4 |
|
|
-7.6 |
| Equity ratio, % |
39.3 |
9.9 |
-22.8 |
-19.1 |
17.9 |
| Debt/equity ratio (net gearing), % |
27.1 |
292.2 |
|
|
195.6 |
| Investments, EUR million |
3.6 |
3.4 |
0.0 |
0.2 |
0.3 |
| % of net sales |
6.9 |
7.1 |
0.0 |
0.5 |
0.5 |
| Research and development, EUR million |
3.6 |
3.3 |
5.3 |
6.0 |
6.5 |
| % of net sales |
6.9 |
7.0 |
12.5 |
10.8 |
10.8 |
| % total expenses (above operating result) |
13.0 |
9.6 |
8.3 |
9.4 |
9.2 |
| Order book, EUR million |
32.1 |
25.5 |
21.1 |
26.2 |
24.9 |
| Personnel, average |
637 |
554 |
604 |
727 |
895 |
| Personnel at the end of the year |
659 |
600 |
543 |
666 |
818 |
| |
|
|
|
|
|
| |
| Key ratios per share |
| Earnings per share, EUR (basic) |
0.05 |
0.03 |
0.00 |
-0.13 |
-0.05 |
| Earnings per share, EUR (diluted) |
0.05 |
0.03 |
0.00 |
-0.13 |
-0.05 |
| Equity per share, EUR |
0.01 |
0.01 |
-0.04 |
-0.05 |
0.09 |
| Number of shares at the end of the period, 1,000 shares |
247,628 |
247,628 |
175,183 |
122,628 |
122,628 |
| Average number of shares, 1,000 shares |
270,293 |
235,295 |
136,559 |
122,628 |
122,628 |
| Number of own shares on 1 Jan, 1,000 shares |
|
|
|
|
|
| Numer of disposed own shares, 1,000 shares |
|
|
|
|
|
| Number of own shares on 31 Dec, 1,000 shares |
10,942 |
|
|
|
|
| Share price, EUR |
|
|
|
|
|
| |
0.34 |
0.09 |
0.07 |
0.09 |
0.11 |
| |
0.11 |
0.05 |
0.04 |
0.07 |
0.09 |
| |
0.90 |
0.24 |
0.11 |
0.13 |
0.17 |
| Share price at the end of the period, EUR |
0.70 |
0.17 |
0.05 |
0.07 |
0.10 |
| Market value at the end of the period, EUR million |
42.1 |
42.1 |
8.1 |
8.6 |
12.2 |
| Share turnover, million shares |
18.3 |
18.3 |
48.2 |
63.3 |
29.7 |
| Share turnover, % of total number |
29.9 |
7.4 |
28.0 |
51.6 |
24.3 |
| Share turnover, EUR million |
35.5 |
2.1 |
4.3 |
5.5 |
3.5 |
| Dividend per share, EUR ³ |
|
|
|
|
|
| Dividend/result, % |
|
|
|
|
|
| Effective dividend yield, % |
|
|
|
|
|
| P/E ratio, % |
13.9 |
5.2 |
|
|
|
| |
|
|
|
|
|
| ¹ Adjusted operating result = operating result before one-time items |
| ² Adjusted result for the period = result for the period without one-time items. |
| ³ The Board of Directors proposes, that no dividend be paid for the financial year ended 31 December 2020. No dividend was paid either for the financial years ended 31 December 2019, 31 December 2018, 31 December 2017 and 31 December 2016. |
